Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 46 (RNA5SP46) is a pseudogene, meaning it is a non-functional DNA sequence that originates from a gene encoding 5S ribosomal RNA (rRNA), but has lost the ability to produce a functional product due to mutations such as insertions, deletions, or premature stop codons[8][6]. 5S rRNA itself is a small component (about 120 nucleotides) of the large ribosomal subunit, essential for ribosome assembly and protein synthesis[1][3][7]. Pseudogenes of 5S rRNA, like RNA5SP46, are common in eukaryotic genomes and are typically not expressed or functional. There is no literature indicating that RNA5SP46 has any therapeutic, biomarker, or disease-related role; it is primarily of genomic and evolutionary interest[8][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 46 (RNA5SP46).